SCHEMBL6238744

SCHEMBL6238744

Cc1c(C(=O)O)ccc(C(=O)Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
TSHR P16473 3/20 0.41
CASP1 P29466 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
MYC P01106 4/20 0.40
NR4A1 P22736 2/20 0.40
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
MT-CO2 P00403 1/20 0.38
LMNA P02545 1/20 0.38
TTR P02766 1/20 0.38
PLA2G1B P04054 1/20 0.38
PGR P06401 1/20 0.38
CYP3A4 P08684 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
AR P10275 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2496346 0.83 CYP1A2 (0.41) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL10625935 0.81 ALDH1A1 (0.37) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL29814908 0.81 CLCN2 (0.47) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL1834641 0.81 CLCN2 (0.47) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL4670497 0.81 TSHR (0.52) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL28873539 0.81 ALOX15 (0.34) NR4A1ALDH1A1MEN1LMNATTR
SCHEMBL31335879 0.79 CA1 (0.48) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL1398470 0.79 CA1 (0.48) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL3116286 0.79 TSHR (0.45) CYP1A2TSHRCASP1SMN1; SMN2MYC
SCHEMBL106326 0.78 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1MEN1LMNAADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005017185-A2 HEPATOCYTE NUCLEAR FACTOR 4α MODULATOR COMPOUNDS LIGAND PHARMCEUTICALS INCORPORATED (US) 2005-02-24 WO disclosed